An interventional study of Automated peritoneal dialysis with Sharesource device and APD without sharesource in Quality of Life and Mental Health Wellness 1, sponsored by Wonju Severance Christian Hospital. Enrolling by invitation at 1 site in Korea, Republic of. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-06-10.
Sponsored by Wonju Severance Christian Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Although peritoneal dialysis (PD) is a representative renal replacement therapy along with hemodialysis, number of PD patients decreases every year. Among the various contributing factors for such trends, the essential issue that the patients should perform dialytic therapy by themselves is thought to be critical for the patients to avoid choosing PD as primary dialytic therapy. In particular, unlike hemodialysis, the patients with PD have troubles in getting timely medical advice in their daily life, although continuous advice are essential for maintaining therapy. Thus, remote monitoring and control system is believed to be useful in PD therapy.
Automated PD (APD) is a good option because of its convenience and improved accessibility. So, in Korea, although the rate of incident PD patients was decreased, the proportion of APD were rapidly increased (3.7% in 2001 vs. 39% in 2018, Korean Society of Nephrology (KSN) data) In the COVID-19 pandemic, the investigators should improve Remote therapy monitoring (RTM). Technologies that collect medical information and transmit it to health care providers for patient management, have the potential to improve the patients' outcomes without visiting hospital receiving automated peritoneal dialysis (APD) at home. However, there are only a few retrospective studies and no prospective study about remote patients monitoring programs in APD. Remote medical service is currently illegal in South Korea. However, recently the Korean government has approved remote medical service in only a few areas of Gangwon province, including Wonju city, which belongs to our institution.
Thus, the investigators aim to use such a benefit to investigate the 'Quality of Life (QOL)' in Korean patients undergoing APD. The investigators plan to compare the various clinical indexes, including mainly QOL, mental health focusing depression, and volume-nutritional status between the patients with previous classic APD and APD combined by the SharesourceTM system (Baxter Co.).
Wonju Severance Christian Hospital is the lead sponsor of 43 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients received APD with Sharesource system
Device: Automated peritoneal dialysis with Sharesource device
Patients received APD without sharesource
Device: APD without sharesource
Patients receive APD with an FMC device that contains sharesource software which can communicate with the medical team.
Patients received APD with Same machine but this patients dose not using sharesource software
changes of quality of life KDQOL-36
Time frame: 6, 12 months
changes of quality of life PHQ-9
Time frame: 6, 12 months
changes of quality of life BDI
Time frame: 6, 12 months
changes of quality of life CESD
Time frame: 6, 12 months
change volume status
Overhydration (measured by bioimpedance device)
Time frame: 6, 12 months
change nutrition status
GNRI (geriatric nutrition risk index), Handgrip strength test (kg)
Time frame: 6, 12 months
dialysis adequacy
KT/V
Time frame: 6,12 months
Questionnaire form.
change of PD perscription, personalized prescription changes, hospital admission, ER admission, unplanned hospital visit, exchanges over telephone
Time frame: 6,12 months
adverse events
peritonitis, mechanical comlications
Time frame: 12 months
Body mass index (BMI: kg/m2)
Time frame: 6 months, 12 months
Total time or PD
Total time of PD
Time frame: 90 Days
Medical coast of treatment
Medical coast
Time frame: 12 month
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Dec 2025; primary completion for Dec 2025, 0 months later.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Wonju Severance Christian Hospital